Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Ikena Oncology, Inc. (IKNA)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
22 Jun 2022
Bonita David P
Director
Ikena Oncology, Inc.
(IKNA)
2,002,062
-11%
252,225
$4.47
$1,128,020.80
SELL
22 Jun 2022
ORBIMED ADVISORS LLC
Director
Ikena Oncology, Inc.
(IKNA)
2,002,062
-11%
252,225
$4.47
$1,128,020.80
SELL
10 Jan 2022
Zhang Xiaoyan Michelle
Chief Scientific Officer, Officer
Ikena Oncology, Inc.
(IKNA)
44,475
-2%
1,000
$12.00
$12,000.00
SELL
10 Dec 2021
Zhang Xiaoyan Michelle
Chief Scientific Officer, Officer
Ikena Oncology, Inc.
(IKNA)
44,475
-2%
1,000
$14.76
$14,759.90
BUY
30 Mar 2021
Bonita David P
Director
Ikena Oncology, Inc.
(IKNA)
2,191,425
+23%
423,400
$16.00
$6,774,400.00
BUY
30 Mar 2021
Atlas Venture Fund XI, L.P.
10% Owner
Ikena Oncology, Inc.
(IKNA)
1,241,935
+8%
98,722
$15.77
$1,614,428.10
BUY
30 Mar 2021
FORMELA JEAN FRANCOIS
Director
Ikena Oncology, Inc.
(IKNA)
1,241,935
+8%
98,722
$15.77
$1,614,428.10
BUY
30 Mar 2021
ORBIMED ADVISORS LLC
Director
Ikena Oncology, Inc.
(IKNA)
2,191,425
+23%
423,400
$16.00
$6,774,400.00
Home